Four new prenylated isoflavones, rhynedulins A-C (1-3) and rhynedulinal (4), were isolated by bioassay-guided fractionation of the dichloromethane bark extract of Rhynchosia edulis. Five previously described compounds, scandenal, ulexin B, cajanone, cajanin, and cyclochandalone, were also isolated. These isoflavonoids showed weak inhibitory activity towards rhodesain, the major cathepsin-L like protease in Trypanosoma brucei. They also have weak antiproliferative activity towards MCF-7 cells.
Rhynchosia edulis Griseb, also known as the Chihuahuan snoutbean is a perennial vine belonging to the Fabaceae family. R. edulis is found predominantly in South and Central America [1] . There have been no previous phytochemical or pharmacological reports on this plant, although a number of glycosylated and prenylated flavonoids have been reported to be present in extracts of plants from the same genus [2] [3] [4] [5] . Using our target-based drug discovery approach for characterizing novel natural products-based therapeutic agents from previously unexplored plant species, we report the isolation and characterization of four new prenylated isoflavones: rhynedulin A (1), rhynedulin B (2), rhynedulin C, (3) and rhynedulinal (4) , four previously characterized isoflavonoids: ulexin B (5), scandenal (6) , cajanin (7) , and cajanone (8) , as well as the isolation of cyclochandalone (9) (cyclochandalone isolated for the first time from a natural source) ( Fig. 1) . These isoflavonoids were isolated from the dichloromethane extract of the bark of R. edulis.
Rhynedulin A (1) was isolated as pale yellow amorphous solid, and its molecular formula was deduced as C 25 H 22 O 5 from the analysis of its HRESIMS and NMR spectroscopic data. The presence of a 1 H singlet resonance at δ H 7.81 and corresponding olefinic oxymethine signal at δ C 152.6 in its 1 H and 13 C NMR spectra (Table 1) , respectively, suggested the presence of an isoflavone skeleton. The 1 H NMR spectrum exhibited a signal at δ H 13.16 (1H, s), suggesting a hydrogen-bonded proton which was assigned to the C-5 hydroxy group. The 1 H NMR and HMBC spectra ( Table 1) also suggested the presence of a 3′′,3′′-dimethyl-1′′,2′′dehydropyran substitution at C-6 and C-7 of its A-ring. The presence of a trisubstituted A-ring was confirmed by the presence of an aromatic proton singlet at δ H 6. 33 (Table 2) , and it was identified as 5-hydroxy-8,
Rhynedulin B (2) was isolated as pale yellow amorphous solid, and its molecular formula was deduced as C 25 H 24 O 6 from the analysis of its HRESIMS and NMR spectroscopic data. The presence of a 1 H singlet resonance at δ H 8.19 and corresponding olefinic oxymethine signal at δ C 154.4 in its 1 H and 13 C NMR spectra (Table 2) , respectively, suggested the presence of an isoflavone skeleton. The 1 H NMR spectrum exhibited a signal at δ H 13.47 indicative of a downfield shifted C-5 hydroxy group due to hydrogen bonding with the C-4 carbonyl group. A 1 H resonance at δ H 6.37 suggested the presence of an aromatic proton at C-8. While its 1 H, 13 C, HSQC and HMBC data ( (Table 3) , respectively, also suggested an isoflavone skeleton. The 1 H NMR spectrum exhibited a signal at δ H 13.14 indicative of a downfield shifted C-5 hydroxy group due to hydrogen bonding with 13 C, COSY, HSQC, HMBC and NOE correlation data (Table 3) , and it was identified as 5-hydroxy-3-
Rhynedulinal (4) and scandenal (6) 1 H NMR spectra indicated the presence of an isoflavone skeleton like other isolated compounds. This was confirmed by the presence of 1 H singlet resonances at δ H 7.95 and 7.88, as well as the corresponding olefinic oxymethine signals at δ C 152.7 and (Table 5) , respectively, suggested an isoflavone skeleton. Further analysis of its 13 C, COSY, HSQC and HMBC NMR data ( Figure 2) confirmed that it is a previously described semisynthetic derivative of chandalone, cyclochandalone (9) [7] . However, this is the first report of the isolation of cyclochandalone from a Other compounds that were isolated from the bark of Rhynchosia edulis include previously characterized prenylated isoflavones: isorobustone (ulexin B, 5) [6, 8, 9] and cajanin (7) [10] [11] [12] [13] and the prenylated isoflavanone, cajanone (8) [14, 15] .
Parasitic diseases remain a major health concern in the tropics and in our continued effort to characterize structural leads for the development of antitrypanosomal agents [16] [17] [18] [19] , the isolated flavonoids were tested for inhibitory activity against the major cathepsin L-like cysteine protease of Trypanosoma brucei rhodesiense, rhodesain. The isoflavones were observed to have weak inhibitory activity towards the protease (Table 6 ). We also carried out molecular docking (Molegro Virtual Docker, v. 4.3.0) of the compounds into the cysteine protease to obtain information about the interactions responsible for their inhibitory activity (as shown for cajanone (8) in Figure 3 ). Favorable interactions were predicted between the benzopyrone ring of the isoflavonoids and active site residues Cys 25, Trp 26, Gly 66, His 162 and Gly 163 of rhodesain. It is also important to add that hydrogen bonding interactions were consistently predicted between the oxygen atoms in the isoflavonoids' benzopyrone motif and the active cysteine (Cys 25) of the protease, as shown for ulexin B (5) in Figure 4 . Similar prenylated flavonoids have been reported in recent times to have antiprotozoal activity [20] [21] [22] although isoflavonoids have been widely noted for their estrogenic effects [23] . It would be interesting to find out in future studies if synthetic structural analogues of these compounds have higher inhibitory activity against the protease and of course if they also have clinically acceptable antitrypanosomal potency.
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In addition, we also tested the compounds for in-vitro cytotoxic activity against the breast cancer cell line, MCF-7. Our data indicated that they all have weak cytotoxicity activity against those cells ( 
Extraction and Isolation:
Air-dried bark of Rhynchosia edulis (673 g) was extracted with refluxing dichloromethane (DCM) for six hours. The solvent was evaporated in vacuo to give an oily dark brownish tar (34.1 g). The crude DCM extract (25.0 g) was subjected to fractionation by flash column chromatography (CC) using silica gel (200-400 mesh) as stationary phase and eluted successively with n-hexane/ethyl acetate (9:1 to 1:1) and ethanol to give 78 fractions. Those fractions were pooled using TLC as a guide to give 13 super-fractions (RE1-RE13). Fractions that displayed activity in our biological assays were subjected to further purification. RE5 (748.7 mg) was subjected to CC on 80 g of silica gel eluted with hexane/ethyl acetate (1:1; ethyl acetate) to give 19 fractions (F1-F19, ~15 ml each). Fractions F3-F6 (272 mg) were pooled and separated on silica gel eluted with hexane/ethyl acetate (4:1) to give 42 fractions (A1-A42, ~20ml each). Ulexin B (5) (3.5 mg, R f 0.33) was obtained by further purification of pooled fractions A6-A8 over silica gel eluted with chloroform/hexane (4:1). RE6 (1 g) was subjected to CC on 80 g of silica gel eluted with chloroform/ethyl acetate (15:1) to give 29 fractions (F1-F29, ~15 ml each). Fractions F2-F4 (34.8 mg) were pooled and further separated on silica gel eluted with hexane/ethyl acetate (10:1) to give 24 fractions (B1-B24, ~ 20 ml each). Scandenal (6) (3.2 mg) and rhynedulinal (4) (3 mg) were obtained from fractions B11-B12 and B19-B21, respectively. Fractions F23-F28 (133.6 mg) were pooled and separated on 15 g of silica gel eluted with hexane/ethyl acetate (3:1) to give 26 fractions (C1-C26, ~ 20 ml each). Fractions C12-15 (11.1 mg) and C16-22 (11.7 mg) were pooled and separated on silica gel eluted with toluene/ethyl acetate (3:1) to give 12 fractions (D1-D12, , ~15 ml each ) and 13 fractions (E1-E13, ~15 ml each), respectively. Rhynedulin A (1) (3.4 mg, R f 0.57) was obtained from D4-D6 while rhynedulin C (3) (6.6 mg, R f 0.43) obtained from E4-E6. RE7 (1 g) was subjected to CC on 80 g of silica gel eluted with DCM/ethyl acetate/ethanol (2:1:0.02) to give 27 fractions (F1-F27, ~15 ml each). Fractions F15-F21 (33.6 mg) were pooled and further separated on silica gel eluted with toluene/ethyl acetate (4:1) to give 25 fractions (E1-E25). Fractions E8-E11 (10.9 mg) were pooled and further separated on silica gel eluted with toluene/ethyl acetate (3:1) to give 11 fractions (G1-G11). Cajanone (8) (1.7 mg, R f 0.47) was obtained from G5. RE8 (5 g) was subjected to CC on 80 g of silica gel eluted with chloroform/acetone (10:1) to give 27 fractions (F1-F27, ~25 ml each). Fractions F12-F25 (1.6 g) were pooled and further separated on silica gel eluted with DCM/ethyl acetate (7:2) to give 34 fractions (H1-H34, ~25 ml each). Fractions H7-H12 (346 mg) were pooled and further separated on silica gel eluted with diethyl ether/chloroform (1:1) to give 17 fractions (J1-J17). 1 H NMR revealed that cajanin (7) (R f 0.58) was present in fractions J5 and J6. Fraction J5 was subjected to recrystallization in ethyl acetate/pentane to give 1.8 mg of pure cajanin (7) . Also, fractions H17-H34 (264 mg) were pooled and further separated on silica gel eluted with DCM/ethyl acetate (3:1) to give 16 fractions (K1-K16). Fractions K8-K14 (172 mg) were pooled and further separated on silica gel eluted with DCM/ethyl acetate (5:1; 1:1) to give 22 fractions (L1-L22). Fractions L11-K15 (74.6 mg) were pooled and further separated on silica gel eluted with chloroform/ethyl acetate (5:1) (1:1) to give 37 fractions (M1-M37, ~15 ml each). Fractions M11-M21 were pooled and separated on silica gel eluted with diethyl ether/DCM (5:1) to give 14 fractions (N1-N14). Cyclochandalone (9) (29.4 mg, R f 0.36) was isolated from fraction N5. RE10 (100 mg) was subjected to CC on 10 g of silica gel eluted with DCM/methanol (15:1) to give 17 fractions (F1-F17, ~30 ml each). Fractions F7-F12 (11 mg) were pooled and separated on silica gel eluted with DCM/ethyl acetate (5:1; 1:1) to give 11 fractions (G1-G11, ~25 ml each). Rhynedulin B (9) (1.8 mg, R f 0.39) was obtained from G4-5 (Figure 4 ).
Rhynedulin A (1)
Pale yellow solid.
